---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-015804"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:48:56.592374+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avalo Therapeutics enters $9M at-the-market equity offering with Oppenheimer

## Summary
- Sales Agreement with Oppenheimer & Co. for up to $9,032,567 of common stock.
- Commission of 3.0% of gross proceeds; ATM offering under Rule 415.
- Shares sold under existing S-3 registration statement effective May 2, 2023.
- Company may suspend or terminate offering; no obligation to sell shares.

## SEC filing metadata
- accession: 0001628280-23-015804
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828023015804/0001628280-23-015804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828023015804/avtx-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-015804
- JSON: https://secwatch.observer/filing/0001628280-23-015804.json
- Plain text: https://secwatch.observer/filing/0001628280-23-015804.txt

## Key facts
- Material Agreements
  Avalo Therapeutics, Inc. entered into Sales Agreement with Oppenheimer & Co. Inc. valued at up to $9,032,567 (effective 2023-05-04).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Oppenheimer & Co. Inc.
  - Value: up to $9,032,567
  - Effective: 2023-05-04
  source text: On May 4, 2023, Avalo Therapeutics, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with Oppenheimer & Co. Inc. (“Oppenheimer”), as sales agent, pursuant to which the Company may offer and sell, from time to time through Oppenheimer, shares of the Company’s common stock, par value $0.001 per share, having an aggregate offering price of up to $9,032,567 (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534120/000162828023015804/0001628280-23-015804-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.